Citizens JMP analyst Devin Ryan lowered the firm’s price target on Dave (DAVE) to $125 from $135 and keeps an Outperform rating on the shares. The recovery in Financial Services business momentum, like in Investment Banking, which started in 2024 and had been accelerating, is now in jeopardy, the analyst tells investors in a research note. Earnings season matters a lot less than the macro right now, the firm says.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVE: